COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD (SUCCESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03994328
Recruitment Status : Recruiting
First Posted : June 21, 2019
Last Update Posted : April 20, 2020
Iqvia Pty Ltd
Information provided by (Responsible Party):
Zambon SpA

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021